← Eichor
Condition: Febrile Neutropenia Fn Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Febrile Neutropenia Fn

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
NA · 1 location(s) · Valeria Cento · NCT07372131Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropen
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT07187908
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.